Active Juvenile Psoriatic Arthritis (DBCOND0137921)

Identifiers

Synonyms

Active Juvenile psoriatic arthritis

Associated Data

Indicated Drugs and Targets

Drug	Description	Targets
Etanercept	A protein therapy based on the binding fragment of the tumour necrosis factor alpha receptor used to treat severe rheumatoid arthritis and moderate to severe plaque psoriasis.	Tumor necrosis factortarget Lymphotoxin-alphatarget Low affinity immunoglobulin gamma Fc region receptor III-Btarget Low affinity immunoglobulin gamma Fc region receptor III-Atarget High affinity immunoglobulin gamma Fc receptor Itarget Low affinity immunoglobulin gamma Fc region receptor II-atarget Low affinity immunoglobulin gamma Fc region receptor II-btarget Low affinity immunoglobulin gamma Fc region receptor II-ctarget Complement component 1q (C1q)target

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT04804553	Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis	Apremilast	treatment	3	recruiting